Drug name - Roxybond

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7955619 PROTEGA PHARMS Abuse resistant drugs, method of use and method of making Aug, 2028

(5 years from now)

US10314788 PROTEGA PHARMS Pharmaceutical compositions configured to deter dosage form splitting Aug, 2028

(5 years from now)

More Information on Dosage
Strength Dosage Availability
5MG TABLET;ORAL Discontinued
15MG TABLET;ORAL Discontinued
30MG TABLET;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.